← Back to Clinical Trials
Recruiting NCT07614386

NCT07614386 Radial Access Data in Vascular Interventions Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07614386
Status Recruiting
Phase
Sponsor Mersin Medicalpark Hastanesi
Condition Radial Artery Occlusion
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2026-05-15
Primary Completion 2030-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Radial and Ulnar Artery Access

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2026-05-15 with a primary completion date of 2030-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access. Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed. The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned. This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access * Ability to provide informed consent Exclusion Criteria: * Age \<18 years * Procedures performed without radial or ulnar artery access * Incomplete procedural or clinical data * Refusal to participate in the registry

Contact & Investigator

Central Contact

Sefa SURAL, MD

✉ sesural@hotmail.com

📞 +90 532 565 01 60

Principal Investigator

Sefa SURAL, MD

STUDY DIRECTOR

Toros University

Frequently Asked Questions

Who can join the NCT07614386 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Radial Artery Occlusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07614386 currently recruiting?

Yes, NCT07614386 is actively recruiting participants. Contact the research team at sesural@hotmail.com for enrollment information.

Where is the NCT07614386 trial being conducted?

This trial is being conducted at Mersin, Turkey (Türkiye).

Who is sponsoring the NCT07614386 clinical trial?

NCT07614386 is sponsored by Mersin Medicalpark Hastanesi. The principal investigator is Sefa SURAL, MD at Toros University. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology